Paramyxovirus, commonly referred to as PMV or OPMV (Ophidian Paramyxovirus), represents one of the most serious viral threats facing captive and wild snake populations worldwide. This highly contagious pathogen belongs to the Paramyxoviridae family and was first identified in a fer-de-lance viper in 1972, earning it the alternative designation of Fer-de-Lance virus. The disease has since been recognized across numerous snake species and geographic regions, establishing itself as a significant concern for snake keepers, breeders, and conservation programs alike.
While paramyxovirus was initially thought to primarily affect viperid snakes, subsequent research and clinical experience have demonstrated that the virus can infect a wide range of snake species including colubrids, boids, and elapids. The virus shows particular virulence in viper species, where mortality rates can approach one hundred percent in naive populations. Pythons and boas appear somewhat less susceptible but can still develop serious disease, and the virus has been documented in numerous colubrid species with varying clinical outcomes depending on species and individual factors.
The impact of paramyxovirus on snake health is profound and multisystemic, though respiratory and neurological signs tend to predominate. The virus targets epithelial cells throughout the respiratory tract, causing severe pneumonia that impairs the snake's ability to breathe and exchange gases effectively. Simultaneously, the virus can invade the central nervous system, producing neurological deficits that may include tremors, incoordination, and an inability to strike prey accurately. Because snakes are ectothermic, their immune response to viral infections is heavily dependent on environmental temperature, and infected snakes kept at suboptimal temperatures often experience accelerated disease progression.
There is currently no cure for paramyxovirus infection in snakes, and no vaccine is commercially available to prevent the disease. Treatment is limited to supportive care measures aimed at maintaining hydration, optimizing environmental conditions, and managing secondary bacterial infections that commonly develop in immunocompromised animals. Early detection is critical for implementing quarantine measures and preventing spread to other snakes, but the prognosis for severely affected individuals remains guarded to poor. Any snake showing respiratory distress or neurological abnormalities should be evaluated immediately by a snake-experienced veterinarian who can perform appropriate diagnostic testing.
